David M. Knott Jr’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

David M. Knott Jr’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Hold	15,000	–	–	1.25%	21
2026 Q1	$1.92M	Buy	15,000 +2,000	+15%	+$250K	1.14%	20
2025 Q4	$1.59M	Buy	13,000 +8,000	+160%	+$917K	0.73%	22
2025 Q3	$501K	Buy	5,000 +2,000	+67%	+$180K	0.2%	52
2025 Q2	$249K	Sell	3,000 -10,643	-78%	-$849K	0.11%	57
2025 Q1	$1.11M	Buy	13,643 +3,643	+36%	+$326K	0.52%	29
2024 Q4	$901K	Hold	10,000	–	–	0.33%	31
2024 Q3	$988K	Sell	10,000 -4,000	-29%	-$393K	0.35%	34
2024 Q2	$1.3M	Sell	14,000 -2,000	-13%	-$179K	0.52%	34
2024 Q1	$1.52M	Buy	16,000 +13,000	+433%	+$1.21M	0.54%	34
2023 Q4	$268K	Buy	+3,000	New	+$223K	0.1%	53
2022 Q3	–	Sell	-800	Closed	-$59K	–	194
2022 Q2	$59K	Hold	800	–	–	0.02%	108
2022 Q1	$72K	Hold	800	–	–	0.02%	114
2021 Q4	$90K	Buy	+800	New	+$96.5K	0.03%	109

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

David M. Knott Jr's XBI Position: Q2 2026 in Review

David M. Knott Jr held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 15,000 shares worth $2.37M. The position accounts for 1.25% of the portfolio, ranked #21.

David M. Knott Jr first reported a position in XBI in Q4 2021 and has held it in 14 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

David M. Knott Jr held 15,000 shares of State Street SPDR S&P Biotech ETF worth $2.37M as of Q2 2026.
David M. Knott Jr left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 1.25% of David M. Knott Jr's portfolio in Q2 2026, its #21 holding.
David M. Knott Jr first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 14 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.